Quinoxaline chemistry. Part 13: 3-carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: Synthesis and evaluation of in vitro anticancer activity

Farmaco

Volumn 55, Issue 2, 2000, Pages 77-86

  Corona, Paola ^a   Vitale, Gabriella ^a   Loriga, Mario ^a   Paglietti, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Anticancer activity; Benzylaminoquinoxalines; Quinoxalines derivatives

Indexed keywords

QUINOXALINE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG PURIFICATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION; GLUTAMATES; HUMANS; NEOPLASMS; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0034018384     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00119-6     Document Type: Article

References (11)

1. Loriga M., Fiore M., Sanna P., Paglietti G. Quinoxaline chemistry. Part 5. 2-(R)-Benzylaminoquinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity. Farmaco. 51:1996;559-568.
2. Loriga M., Piras S., Sanna P., Paglietti G. Quinoxaline chemistry. Part 7. 2-[Aminobenzoates]- and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents: synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity. Farmaco. 52:1997;157-166.
3. Loriga M., Moro P., Sanna P., Paglietti G. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents: synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity. Farmaco. 52:1997;531-537.
4. Vitale G., Corona P., Loriga M., Paglietti G. Quinoxaline chemistry. Part 12. 3-Carboxy-2-[phenoxy]-6(7)-substituted quinoxalines and N-[4-(6(7)-substituted-3-carboxyquinoxalin-2-yl)hydroxy]benzoylglutamates: synthesis and evaluation of in vitro anticancer activity. Farmaco. 53:1998;594-601.
5. M. Loriga, P. Sanna, G. Paglietti, Chinossaline come antifolici analoghi del Metotressato e Trimetrexato, Atti del XIII Convegno Nazionale della Divisione di Chimica Farmaceutica, Paestum, 23-27 Settembre, 1996, p. 145.
6. G. Vitale, P. Corona, M. Loriga, G. Paglietti, Quinoxalines as novel potential antitumor agents. First Italian-Swiss Meeting on Medicinal Chemistry, Turin, 23-26 September, 1997, pp. 193, 194.
7. Loriga M., Fiore M., Sanna P., Paglietti G. Quinoxaline chemistry. Part 4. 2-(R)-anilinoquinoxalines as non classic antifolate agents: synthesis, structure elucidation and evaluation of in vitro anticancer activity. Farmaco. 50:1995;289-301.
8. Gangjee A., Devraj R., McGuire J.T., Kirlink R.L. Effect on bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diamminofuro[2,3-d]pyrimidines. J. Med. Chem. 38:1995;3798-3805.
9. Sanna P., Carta A., Loriga M., Zanetti S., Secchi L. Synthesis of substituted 2-ethoxycarbonyl and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity. Farmaco. 53:1998;455-461.
10. Boyd M.R. Status of the NCI preclinical antitumor drug discovery screen. Princ. Pract. Oncol. 3:1989;1-12.
11. Weislow O.W., Kiser R., Fine D., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.